Regulated Necrosis in Pulmonary Disease. A Focus on Necroptosis and Ferroptosis

Area of Science:

• Cell Biology
• Pulmonology
• Immunology

Background:

• Emerging evidence links diverse cell death types to lung disease pathogenesis.
• Regulated cell death, such as immunogenic necrotic cell death, releases damage-associated molecular patterns, promoting inflammation.
• Necroptosis, driven by RIPK3 and MLKL, and ferroptosis, characterized by iron-dependent lipid peroxidation, are key regulated necrosis pathways.

Purpose of the Study:

• To review the role of regulated necrotic cell death, specifically necroptosis and ferroptosis, in lung disease.
• To examine the involvement of key effector molecules in these cell death pathways within lung disease contexts.

Main Methods:

• Literature review of studies on regulated cell death in lung diseases.
• Analysis of the roles of RIPK3, MLKL, and iron-dependent lipid peroxidation in necroptosis and ferroptosis.
• Examination of shared mechanisms and synergistic effects between necroptosis and ferroptosis.

Main Results:

• Necroptosis and ferroptosis play distinct yet sometimes overlapping roles in lung disease.
• Key molecules like RIPK3, MLKL, and iron metabolism are critical regulators.
• Some models show shared pathways and synergistic effects of inhibiting both necroptosis and ferroptosis.

Conclusions:

• Regulated necrosis, including necroptosis and ferroptosis, is integral to lung disease pathogenesis.
• Further research into these pathways and their effectors may reveal novel therapeutic targets for lung diseases.